Transformation of myelodysplastic syndrome to acute megakaryoblastic
leukemia: An aggressive disease
- Ganesh Kasinathan
, - Bee Sun Lee
Abstract
A 59-year old gentleman with transformation of myelodysplastic syndrome
to acute megakaryoblastic leukemia was treated with standard intensive
chemotherapy. His poor outcome was attributed to advanced age,
aggressive disease biology, underlying myelodysplastic syndrome, poor
response to induction chemotherapy, high lactate dehydrogenase and lack
of good cytogenetic and molecular mutations.14 Nov 2020Submitted to Clinical Case Reports 17 Nov 2020Submission Checks Completed
17 Nov 2020Assigned to Editor
24 Nov 2020Reviewer(s) Assigned
27 Jan 2021Review(s) Completed, Editorial Evaluation Pending
02 Feb 2021Editorial Decision: Revise Minor
04 Feb 20211st Revision Received
06 Feb 2021Submission Checks Completed
06 Feb 2021Assigned to Editor
06 Feb 2021Review(s) Completed, Editorial Evaluation Pending
05 Mar 2021Editorial Decision: Accept
